October 2017
By Jadwiga A. Wedzicha, MD, editor, American Journal of Respiratory and Critical Care Medicine
Follow Dr. Wedzicha on Twitter @ATSBlueEditor
The Timing of Early Antibiotics and Hospital Mortality in Sepsis
Just how life-saving is the early administration of antibiotics in sepsis? In their Oct. 1 American Journal of Respiratory and Critical Care Medicine article, Vincent X. Liu and colleagues attempt to answer that question by analyzing the records of 35,000 patients whose care was guided by a multicenter quality improvement program that had all sepsis patients on antibiotics within six hours of emergency department registration. The study found each hour’s delay in antibiotic treatment increased absolute mortality by 0.3 percent for sepsis, 0.4 percent for severe sepsis, and 1.8 percent for shock. The authors said the findings “support currently held beliefs that administering early antibiotics to infected patients with systemic inflammation is beneficial for reducing mortality” and demonstrate the value of analyzing electronic medical records to clarify medical issues that would not be ethical to study through randomized, controlled clinical trials.
AJRCCM Highlights
Oct. 1
Hypoxic Pulmonary Vasoconstriction Does Not Explain All Regional Perfusion Redistribution in Asthma
Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages
Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes: A Longitudinal Study
Oct. 15
Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma
Spirometry Reference Equations from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis
Combined Impact of Smoking and Early Life Exposures on Adult Lung Function Trajectories
AJRCCM Launches Blue Briefing Video Series
The American Journal of Respiratory and Critical Care Medicine has launched the first installment of Blue Briefing, a video series that will provide quick, informative summaries of some of the most groundbreaking and important articles published in the Journal. In this Blue Briefing, we highlight the comparison of outcomes in patients 65-74 years old from SEER-Medicare and NLST datasets in stage I lung cancer. Take a look.